Particle News: Latest BioNTech SE news

U.S. Health Officials to Present Claim Linking 25 Child Deaths to COVID Vaccines to CDC Advisory Panel

HHS says the VAERS-based analysis remains preliminary, with data not yet shared publicly.

Pumitamig Shows High Response in First-Line Small Cell Lung Cancer Phase 2

UK Invests £29.6 Million in Darlington RNA Biofoundry to Accelerate New Therapies

mRNA Neoantigen Vaccine Amplifies Anti-PD-1 Immunity and Suppresses Gastric Cancer Spread in Mice

NHS Begins Phase II/III Trial of mRNA Vaccine for Head and Neck Cancer

GSK Secures $370 Million After CureVac US Patent Settlement

Biontech, Curevac Agree on $740 Million Covid-19 Vaccine Patent Settlement

BioNTech Halves Q2 Loss as mRNA Cancer Pipeline Advances

BioNTech Moves to Complete $1.25 Billion Curevac Takeover

BioNTech to Acquire CureVac for $1.25 Billion to Drive mRNA Cancer Therapy

BioNTech to Acquire CureVac for $1.25 Billion

Germany Awards National Prize to Biontech Founders Sahin and Türeci

Bristol Myers Squibb and BioNTech partner on $11 billion bispecific antibody cancer drug

UK Finalizes £1bn BioNTech Deal to Advance mRNA Cancer Vaccines and AI Research

Biontech Reports Q1 Loss as Focus Shifts to mRNA Cancer Therapies

Same-Arm Boosters Found to Enhance Early Vaccine Response

HHS Secretary RFK Jr. Weighs Removing COVID-19 Vaccine From Childhood Schedule

Biontech Reports €700 Million Loss and Plans Workforce Restructuring

Moderna Wins Patent Case Against BioNTech and Pfizer Over mRNA Technology